CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.360
-0.030 (-7.72%)
Apr 29, 2026, 3:02 PM EDT - Market open

CollPlant Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-11.49-16.61-7.02-16.930.24
Upgrade
Depreciation & Amortization
0.911.041.11.080.77
Upgrade
Loss (Gain) From Sale of Assets
--0.02--
Upgrade
Stock-Based Compensation
11.721.942.171.6
Upgrade
Other Operating Activities
-0.10.130.350.52-0.32
Upgrade
Change in Accounts Receivable
0.15-0.150.010.260.56
Upgrade
Change in Inventory
-0.130.280.75-0.310.18
Upgrade
Change in Accounts Payable
-0.26-0.11-0.150.10.24
Upgrade
Change in Unearned Revenue
----0.03-0.18
Upgrade
Change in Other Net Operating Assets
0.49-0.390.24-0.56-0.59
Upgrade
Operating Cash Flow
-9.42-14.09-2.76-13.72.5
Upgrade
Capital Expenditures
-0.03-0.48-0.95-1.27-1.43
Upgrade
Sale of Property, Plant & Equipment
000.07-0.03
Upgrade
Sale (Purchase) of Intangibles
----0.04-0.16
Upgrade
Investment in Securities
---30.24-30
Upgrade
Other Investing Activities
--0.06-0.27--
Upgrade
Investing Cash Flow
-0.03-0.54-1.1628.92-31.56
Upgrade
Issuance of Common Stock
3.10.011.111.8738.76
Upgrade
Financing Cash Flow
3.10.011.111.8738.76
Upgrade
Foreign Exchange Rate Adjustments
0.03-0.14-0.38-0.610.14
Upgrade
Net Cash Flow
-6.32-14.77-3.1916.499.85
Upgrade
Free Cash Flow
-9.45-14.58-3.72-14.971.07
Upgrade
Free Cash Flow Margin
-398.44%-2830.29%-33.92%-5007.36%6.86%
Upgrade
Free Cash Flow Per Share
-0.77-1.27-0.33-1.360.09
Upgrade
Cash Income Tax Paid
0.020.060.010.03-
Upgrade
Levered Free Cash Flow
-5.48-8.89-1.9-8.90.94
Upgrade
Unlevered Free Cash Flow
-5.48-8.89-1.9-8.890.95
Upgrade
Change in Working Capital
0.25-0.370.85-0.540.22
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.